News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Shah Pratik
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/28/2023 |
4
| Shah Pratik (10% Owner) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.5, valued at
$260k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Shah Pratik (10% Owner) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 10,156,204 shares
@ $0
Granted 354,570 options to buy
@ $1.44, valued at
$510.6k
|
|
| 11/10/2022 |
3
| Shah Pratik (10% Owner) has filed a Form 3 on ARS Pharmaceuticals, Inc. |
| 02/02/2022 |
4
| Shah Pratik (Executive Chairperson) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Granted 475,000 options to buy
@ $12.77, valued at
$6.1M
|
|
| 04/01/2021 |
4
| Shah Pratik (Executive Chairperson) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Bought 25,000 shares
@ $20, valued at
$500k
Converted 104,923 shares
@ $0
Converted 171,025 preferred shares
@ $0 |
|
| 03/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/24/2020 |
4
| Shah Pratik (Director) has filed a Form 4 on Synthorx, Inc.|
Txns:
| Unknown transaction of 62,412 shares
@ $68, valued at
$4.2M
Disposed/sold 10,223 options to buy
@ $12.4, valued at
$126.8k
|
|
| 06/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2018 |
3
| Shah Pratik (Director) has filed a Form 3 on Synthorx, Inc. |
| 05/06/2015 |
4
| Shah Pratik (President and CEO) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 903,018 shares
@ $0
Disposed/sold 215,153 options to buy
@ $6.57, valued at
$1.4M
Disposed/sold 200,000 options to buy
@ $59.66, valued at
$11.9M
Disposed/sold 100,000 restricted stock units
@ $0 |
|
| 02/04/2015 |
4
| Shah Pratik (President and CEO) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Granted 200,000 options to buy
@ $59.66, valued at
$11.9M
Granted 100,000 restricted stock units
@ $0 |
|
| 02/12/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/23/2013 |
4
| Shah Pratik (Director) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $7.85, valued at
$157k
|
|
| 07/17/2013 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 07/17/2013 |
3
| Shah Pratik (Director) has filed a Form 3 on Ocera Therapeutics, Inc. |
|
|